Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 584.52% and ...

Ahara Corporation, announced today its adding doctor-prescribed compounded GLP-1/GIP weight loss medications to its personalized nutrition offering. The semaglutide or tirzpetide medications are ...

Many GLP-1 users suddenly discover they don't have as much "food noise" or constant thoughts about eating anymore. They also ...

Adults over 18 years of age are needed to participate in nutrition study to learn more about the effects of protein on body ...

While Ozempic and similar medications are all the buzz right now, many of us still aren’t sure what they actually are or how they work! This video breaks down all the essential details to help you ...

In July, the U.S. Food and Drug Administration warned that people are overdosing on compounded semaglutide injectable ...

Here are key takeaways from latest research and a session of the European Association of the Study of Diabetes (EASD) ...

Meanwhile, Lilly’s 2023 revenue exceeded $34 billion, growing 20% year-over-year. Its tirzepatide brands Mounjaro and ...

Jim Cramer warned that if the housing market rally keeps going, it might lead to a sell-off if the Federal Reserve announces ...

The demand for medications like Ozempic continues to cause shortages for both those seeking weight loss and patients with ...

In an unconventional alliance, North Carolina State Treasurer Dale Folwell, a Republican, spoke on Capitol Hill at a ...

Eli Lilly and Company ’s LLY stock has risen 21.1% in six months compared with an increase of 10.5% for the industry. The ...